Edvard Nordfors new CFO of NovaHep AB

Edvard Nordfors will assume the position as Chief Financial Officer at NovaHep AB, starting July 1, 2016.


“We are very pleased to announce that Edvard Nordfors will be joining our team to assume an instrumental role in NovaHep’s continued development and path towards commercialization. Edvard brings extensive international experience in financial management, M&A and investments from both large and small companies across several industries, including the life science industry”, says NovaHep CEO Petter Björquist.


NovaHep AB is a Swedish regenerative medicine company with a unique technology for engineering a broad range of biocompatible tissues and organs. NovaHep’s products in development rely on patient-individualization of donated organs and tissues by applying advanced, proprietary technology for de- and recellularization. The current focus lies on preparing for a clinical trial, the first of its kind in the world, with veins tissue-engineered by NovaHep. NovaHep is located in central Gothenburg in close vicinity to Sahlgrenska University Hospital.


For further information, please contact Petter Björquist at petter.bjorquist@novahep.com or call +46 705 97 92 96.